Scandinavian Journal of Infectious Diseases · 1970 · 10 citations · 6 references
MedicineInfectious DiseasesPharmacologyAntimicrobial PharmacologyChemotherapyPharmaceutical ToxicologyAntimicrobial ToxicityAntiparasitic AgentsAntiparasitic ChemotherapyAntiparasitic PharmacologyAntiparasitic PharmacotherapyAmoebiasis ChemotherapyAntiparasitic Drug TherapyChemotherapeutic ToxicologyChemotherapy Of Protozoal InfectionsChemotherapy Of Protozoan InfectionsDrug Safety MarginSafety MarginTherapeutic Index Determination
The chemotherapeutic activity and the toxicity of some nitroheterocycles used in antiparasitic therapy (aminitrozole, 2-α-thenoylamino-5-nitrothiazole, niridazole, furazolidone, nifuratel and metronidazole) were compared in laboratory tests. Metronidazole appeared as the most active compound against trichomoniasis and amoebiasis and had in addition the widest safety margin; it also had the highest therapeutic index against lambliasis. Niridazole while showing activity against these protozoa had a less favourable therapeutic index but was the only one which was very active against bilharziasis. Furazolidone appeared as a specially good antibacterial agent with a good activity against Iambliasis. Aminitrozole showed a wide spectrum of activity; its safety margin was slightly lower, however. The other two (2-α-thenoylamino-5-nitrothiazole and nifuratel) were less active and showed a narrower spectrum of activity.
6